• 1
    Zhao X, Huang L. Cardiac stem cells: a promising treatment option for heart failure. Exp Ther Med. 2013; 5: 37983.
  • 2
    Dergilev KV, Rubina KA, Parfenova EV. Resident cardiac stem cells. Kardiologiia. 2011; 51: 8492.
  • 3
    Perez Millan MI, Lorenti A. Stem cells and cardiac regeneration. Medicina. 2006; 66: 57482.
  • 4
    Rajabi-Zeleti S, Jalili-Firoozinezhad S, Azarnia M, et al. The behavior of cardiac progenitor cells on macroporous pericardium-derived scaffolds. Biomaterials. 2014; 35: 97082.
  • 5
    Tokunaga M, Liu ML, Nagai T, et al. Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. J Mol Cell Cardiol. 2010; 49: 97283.
  • 6
    Liang SX, Khachigian LM, Ahmadi Z, et al. In vitro and in vivo proliferation, differentiation and migration of cardiac endothelial progenitor cells (SCA1+/CD31+ side-population cells). J Thromb Haemost. 2011; 9: 162837.
  • 7
    Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA. 2003; 100: 123138.
  • 8
    Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem. 2004; 279: 1138491.
  • 9
    Noor N, Patel CB, Rockman HA. Beta-arrestin: a signaling molecule and potential therapeutic target for heart failure. J Mol Cell Cardiol. 2011; 51: 53441.
  • 10
    Vinge LE, Oie E, Andersson Y, et al. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. Am J Physiol Heart Circ Physiol. 2001; 281: H24909.
  • 11
    Ambros V. The functions of animal microRNAs. Nature. 2004; 431: 3505.
  • 12
    Corsten MF, Papageorgiou A, Verhesen W, et al. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ Res. 2012; 111: 41525.
  • 13
    Liu J, van Mil A, Vrijsen K, et al. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med. 2011; 15: 147482.
  • 14
    Mohri T, Fujio Y, Maeda M, et al. Leukemia inhibitory factor induces endothelial differentiation in cardiac stem cells. J Biol Chem. 2006; 281: 64427.
  • 15
    Li Z, Guo X, Matsushita S, et al. Differentiation of cardiosphere-derived cells into a mature cardiac lineage using biodegradable poly(N-isopropylacrylamide) hydrogels. Biomaterials. 2011; 32: 322032.
  • 16
    Chua CC, Gao J, Ho YS, et al. Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice. Cardiovasc Res. 2009; 81: 207.
  • 17
    Xie N, Li H, Wei D, et al. Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis. Neuropharmacology. 2010; 59: 44451.
  • 18
    Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009; 324: 98102.
  • 19
    Ryzhov S, Zhang Q, Biaggioni I, et al. Adenosine A2B receptors on cardiac stem cell antigen (Sca)-1-positive stromal cells play a protective role in myocardial infarction. Am J Pathol. 2013; 183: 66572.
  • 20
    Yan X, Ehnert S, Culmes M, et al. 5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation. PLoS ONE. 2014; 9: e90846.
  • 21
    Elton TS, Selemon H, Elton SM, et al. Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 2013; 532: 112.
  • 22
    Cho J, Rameshwar P, Sadoshima J. Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. J Biol Chem. 2009; 284: 3664758.
  • 23
    Feng Z, Xia Y, Zhang M, et al. MicroRNA-155 regulates T cell proliferation through targeting GSK3beta in cardiac allograft rejection in a murine transplantation model. Cell Immunol. 2013; 281: 1419.
  • 24
    Jeong CW, Yoo KY, Lee SH, et al. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3beta and inhibition of p38 MAPK and JNK. J Cardiovasc Pharmacol Ther. 2012; 17: 38794.
  • 25
    Cho J, Zhai P, Maejima Y, et al. Myocardial injection with GSK-3beta-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. Circ Res. 2011; 108: 47889.
  • 26
    Bathgate-Siryk A, Dabul S, Pandya K, et al. Negative impact of beta-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension. 2014; 63: 40412.
  • 27
    Lohse MJ, Hoffmann C. Arrestin interactions with G protein-coupled receptors. Handb Exp Pharmacol. 2014; 219: 1556.